P109 ORAL PRESENTATIONS males. The incidence of brachycephaly was 0.9% in females and 1.6% in males. Of those noted to have abnormal facial characteristics (telecanthus, frontal prominence), 40% had plagiocephaly and 6.7% had brachycephaly.
Objective: 1) Present outcomes of surgically treated infantile hemangioma, and describe changes in surgical management with the advent of changes in medical therapy. 2) Highlight the role of imaging in surgical planning. 3) Identify risk factors for surgical complications.
Method: Retrospective chart review of patients in a multidisciplinary clinic diagnosed with infantile hemangioma involving soft tissue and skin between 2008 and 2010. Data relating to demographics, indications for surgery, histopathology analysis, postoperative care, and complications were collected.
Results: Of 1050 subjects, 109 patients (10%) underwent surgical intervention, and 78% of the lesions were in the head and neck. Ulceration, bleeding, and deformity were the major surgical indications. Seven patients underwent staged excision. Magnetic resonance imaging was utilized in diagnostic workup and preoperative planning in 15 cases. Adjunctive medical therapy was safely used in 26% of the surgical cohort. Head and neck lesions were more likely to receive adjunctive therapy (P = .007) and had a higher complication rate. Overall complication rate was lower (6%) compared with our 2005-2007 surgery cohort (1012 patients) with a complication rate of 17%.
Conclusion: Surgery continues to be a viable form of therapy for complicated infantile hemangiomas. Introduction of propanolol and vincrinstine for challenging lesions did not change the surgery rate but may partly explain the lower complication rate secondary to preoperative reduction of surgical bulk.
Pediatric Otolaryngology injection Augmentation for Type i laryngeal Clefts Hamdy El-Hakim, FRCS (presenter); Harshdeep Singh Mangat
Objective: Describe a series of children diagnosed with type I congenital laryngeal clefts (LC-I) and treated due to various presentations with endoscopic injection augmentation (IA).
Method: This is a retrospective study. The children were identified from a prospectively collected database. Only those who were treated with IA (using hyaluronic acid derivatives) and had a minimum follow-up of 3-months were included. We collected demographics, diagnoses, surgical procedures, number of IA, clinical outcomes, and complications.
Results: Over a period of 8 years, 32 patients were diagnosed with LC-I. Fifteen had undergone IA over the past 3 years. Mean age at IA was 28.67 ± 17.54 months with a male-tofemale ratio of 8:7. The indications were swallowing dysfunction (13) and atypical croup (2). Seven patients required repeated injections (mean of 2.57 injections). A total of 10 patients responded with resolution of symptoms in question. No record of complications was found.
Conclusion: IA is a brief, simple management option that succeeds in a number of children with LC-I. It is minimally morbid and supplements other conservative approaches to treat the condition.
